European League Against Rheumatism Companies
EULAR aims to be a central platform to facilitate and stimulate innovative basic and clinical research projects in rheumatic.
Headquarters:
Germany
Funding Status:
IPO
Estimated Revenue:
Less than $1M
Technology:
Assistive technologies
Industry:
Innovation, Technology, and Research